Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies
  2. Wei, Q.; Jiang, H.; Matthews, C. P.; Colburn, N. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(50): 19738-19743.
  1. 2.   A paracrine signal mediates the cell transformation response to low dose gamma radiation in JB6 cells
  2. Weber, T. J.; Siegel, R. W.; Markille, L. M.; Chrisler, W. B.; Lei, X. Y. C.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2005, MAY; 43(1): 31-37.
  1. 3.   Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation
  2. Dhar, A.; Hu, J.; Reeves, R.; Resar, L. M. S.; Colburn, N. H.
  3. Oncogene. 2004 23(25): 4466-4476.
  1. 4.   Nitric oxide does not mediate but inhibits transformation and tumor phenotype
  2. Dhar, A.; Brindley, J. M.; Stark, C.; Citro, M. L.; Keefer, L. K.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2003 2(12): 1285-1293.
  1. 5.   A dominant negative c-jun specifically blocks okadaic acid- induced skin tumor promotion
  2. Thompson, E. J.; MacGowan, J.; Young, M. R.; Colburn, N.; Bowden, G. T.
  3. Cancer Research. 2002 62(11): 3044-3047.
  1. 6.   The role of AP-1, NF-kappa B and ROS/NOS in skin carcinogenesis: The JB6 model is predictive
  2. Dhar, A.; Young, M. R.; Colburn, N. H.
  3. Molecular and Cellular Biochemistry. 2002 234(1): 185-193.
  1. 8.   A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappa B or ODC transactivation
  2. Yang, H. S.; Jansen, A. P.; Nair, R.; Shibahara, K.; Verma, A. K.; Cmarik, J. L.; Colburn, N. H.
  3. Oncogene. 2001 20(6): 669-676.
  1. 9.   Activator protein 1 (AP-1)- and nuclear factor kappa B (NF-kappa B)-dependent transcriptional events in carcinogenesis
  2. Hsu, T. C.; Young, M. R.; Cmarik, J.; Colburn, N. H.
  3. Free Radical Biology and Medicine. 2000 28(9): 1338-1348.
  1. 10.   Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation
  2. Cmarik, J. L.; Min, H. Z.; Hegamyer, G.; Zhan, S. N.; Kulesz-Martin, M.; Yoshinaga, H.; Matsuhashi, S.; Colburn, N. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(24): 14037-14042.
  1. 11.   Tumor promoter benzoyl peroxide induces sulfhydryl oxidation in protein kinase C: Its reversibility is related to the cellular resistance to peroxide-induced cytotoxicity
  2. Gopalakrishna, R.; Gundimeda, U.; Anderson, W. B.; Colburn, N. H.; Slaga, T. J.
  3. Archives of Biochemistry and Biophysics. 1999 363(2): 246-258.
  1. 12.   Tumor Promoter Induces High Mobility Group Hmg-Y Protein Expression in Transformation-Sensitive But Not -Resistant Cells
  2. Cmarik, J. L.; Li, Y.; Ogram, S. A.; Min, H. Z.; Reeves, R.; Colburn, N. H.
  3. Oncogene. 1998 16(26): 3387-3396.
  1. 14.   Grafting Assay Distinguishes Promotion Sensitive From Promotion Resistant Jb6 Cells
  2. Strickl, J.; Sun, Y.; Dong, Z. G.; Colburn, N. H.
  3. Carcinogenesis. 1997 18(6): 1135-1138.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel